C. Barnes

发表

Canadian multi‐institutional survey of immune tolerance therapy (ITT) – experience with the use of recombinant factor VIII for ITT

V. Blanchette, M. Carcao, M. Poon, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

Nonacog beta pegol (N9‐GP) in hemophilia B: First report on safety and efficacy in previously untreated and minimally treated patients

A. Chuansumrit, G. Young, C. Barnes, 2020, Research and practice in thrombosis and haemostasis.

Paediatric stroke: The need for interdisciplinary models of care

M. Mackay, A. Gordon, C. Barnes, 2009, Journal of paediatrics and child health.

Reduced bone density among children with severe hemophilia.

Graeme Jones, P. Monagle, F. Cameron, 2004, Pediatrics.

Laryngo-pharyngeal carcinoma in childhood.

C. Barnes, R. Berkowitz, M. Sexton, 2001, International journal of pediatric otorhinolaryngology.

Benchmarking the management of children with haemophilia in Australia

S. Brown, C. Barnes, R. Suppiah, 2014, Journal of paediatrics and child health.

Attitudes towards and beliefs about genetic testing in the haemophilia community: a qualitative study

P. Komesaroff, A. Street, C. Barnes, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Severe haemophilia and extreme prematurity – a case report

C. Barnes, B. Gelbart, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

How we use recombinant activated Factor VII in patients with haemophilia A or B complicated by inhibitors

S. Brown, C. Barnes, S. Dunkley, 2012, Internal medicine journal.

Human plasma-derived FVIII/VWD concentrate (Biostate): a review of experimental and clinical pharmacokinetic, efficacy and safety data

E. Favaloro, C. Barnes, S. Dunkley, 2016, Drugs in context.

Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A

J. Mahlangu, R. Liesner, B. Nolan, 2015, Journal of thrombosis and haemostasis : JTH.

When is enough … enough? Developing consensus of definition of failure of immune tolerance induction in patients with haemophilia and inhibitors

S. Brown, C. Barnes, S. Dunkley, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

The clinical efficacy and safety of the FVIII/VWF concentrate, BIOSTATE®, in children with von Willebrand disorder: a multi‐centre retrospective review

C. Barnes, R. Suppiah, J. Curtin, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Congenital Methemoglobinemia Type II—Clinical Improvement with Short‐Term Methylene Blue Treatment

C. Barnes, A. Greenway, M. Cooper, 2016, Pediatric blood & cancer.

Prothrombotic abnormalities in childhood ischaemic stroke.

G. deVeber, C. Barnes, 2006, Thrombosis research.

Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study

J. Oldenburg, E. Santagostino, B. Konkle, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Intracranial haemorrhage in children and adolescents with severe haemophilia A or B – the impact of prophylactic treatment

G. Auerswald, R. Ljung, M. Carcao, 2017, British journal of haematology.

Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B.

J. Oldenburg, D. Perry, M. Ozelo, 2016, Thrombosis and haemostasis.

Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein ( rFIXFc ) in subjects with haemophilia

J. Oldenburg, D. Perry, M. Ozelo, 2017 .

Recent Advances in Haemophilia Management

C. Barnes, 2015, Current Pediatrics Reports.

Pharmacokinetics of recombinant factor VIII (Kogenate‐FS®) in children and causes of inter‐patient pharmacokinetic variability

V. Blanchette, M. Carcao, D. Lillicrap, 2006 .

Novel and Clinically Significant Factors Influencing the Pharmacokinetic Variability of Recombinant Factor VIII (Kogenate-FS) in Children.

V. Blanchette, M. Carcao, D. Lillicrap, 2004 .

Importance of pharmacokinetics in the management of hemophilia

C. Barnes, 2013, Pediatric blood & cancer.

A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A Subjects

J. Blatny, M. Morfini, V. Blanchette, 2021, Thrombosis and Haemostasis.

Challenges in hemophilia care in Australia and New Zealand

S. McRae, S. Brown, C. Barnes, 2015, Current medical research and opinion.

Different clinical phenotype in triplets with haemophilia A

M. Carcao, J. Leggo, D. Lillicrap, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure: progress report.

C. Barnes, T. Brewin, H. Ekert, 2001 .

Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure: progress report

C. Barnes, T. Brewin, H. Ekert, 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

Safety, Efficacy, and Pharmacokinetics of Recombinant Factor VIII FC Fusion Protein (RFVIIIFC) in Previously Treated Paediatric Subjects with Severe Haemophilia A (Kids A-LONG)

J. Mahlangu, B. Nolan, G. Young, 2013 .

Safety, Efficacy, and Pharmacokinetics of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously-Treated Children with Severe Hemophilia a (Kids-ALONG)

J. Mahlangu, B. Nolan, G. Young, 2014 .

Reduced Bone Density in Children on Long-Term Warfarin

Vera Ignjatovic, Paul Monagle, P. Monagle, 2005, Pediatric Research.

Paraganglioma of the external auditory canal: an unusual case.

C. Barnes, C. Timon, A. Curran, 2000, The Journal of laryngology and otology.

Aspergillus laryngotracheobronchial infection in a 6-year-old girl following bone marrow transplantation.

C. Barnes, N. Curtis, R. Berkowitz, 2001, International journal of pediatric otorhinolaryngology.

Helicobacter pylori and tonsillectomy.

D. Winter, C. Barnes, C. Timon, 2001, Clinical otolaryngology and allied sciences.

Induction of immune tolerance using rituximab in a child with severe haemophilia B with inhibitors and anaphylaxis to factor IX

P. Monagle, L. Donnan, C. Barnes, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Estimation of transient increases in bleeding risk associated with physical activity in children with haemophilia

P. Monagle, R. Herbert, J. Latimer, 2008, BMC blood disorders.

Case report Laryngo-pharyngeal carcinoma in childhood

C. Barnes, R. Berkowitz, M. Sexton, 2001 .

Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure

C. Barnes, Z. Rudzki, H. Ekert, 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical significance of two mutations in the factor IX gene in a family with haemophilia B

R. Savarirayan, C. Barnes, J. Furmedge, 2010, Haemophilia.

Vacuolated lymphocytes–a diagnostic clue

C. Barnes, H. Goel, K. Radhakrishnan, 2010, European journal of haematology.

Delayed diagnosis of congenital factor IX deficiency (Christmas disease) in a girl with Turner's Syndrome.

P. Monagle, C. Barnes, G. Kelsey, 2006, Clinical and laboratory haematology.

Penetrating injury to the heart in a patient with haemophilia

C. Barnes, P. Antippa, A. Tuckfield, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.